Endoscopy Systems
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Endometriosis Market Research Report 2023
1 Endometriosis Market Overview
1.1 Product Overview and Scope of Endometriosis
1.2 Endometriosis Segment by Type
1.2.1 Global Endometriosis Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Gonadotropins Releasing Hormone Agonists
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Progestin
1.2.5 Oral Contraceptive Pills
1.3 Endometriosis Segment by Application
1.3.1 Global Endometriosis Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Other
1.4 Global Endometriosis Market Size Estimates and Forecasts
1.4.1 Global Endometriosis Revenue 2017-2028
1.4.2 Global Endometriosis Sales 2017-2028
1.4.3 Endometriosis Market Size by Region: 2017 Versus 2021 Versus 2028
2 Endometriosis Market Competition by Manufacturers
2.1 Global Endometriosis Sales Market Share by Manufacturers (2017-2022)
2.2 Global Endometriosis Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Endometriosis Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Endometriosis Manufacturing Sites, Area Served, Product Type
2.5 Endometriosis Market Competitive Situation and Trends
2.5.1 Endometriosis Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Endometriosis Players Market Share by Revenue
2.5.3 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endometriosis Retrospective Market Scenario by Region
3.1 Global Endometriosis Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Endometriosis Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Endometriosis Market Facts & Figures by Country
3.3.1 North America Endometriosis Sales by Country
3.3.2 North America Endometriosis Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Endometriosis Market Facts & Figures by Country
3.4.1 Europe Endometriosis Sales by Country
3.4.2 Europe Endometriosis Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Endometriosis Market Facts & Figures by Region
3.5.1 Asia Pacific Endometriosis Sales by Region
3.5.2 Asia Pacific Endometriosis Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Endometriosis Market Facts & Figures by Country
3.6.1 Latin America Endometriosis Sales by Country
3.6.2 Latin America Endometriosis Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Endometriosis Market Facts & Figures by Country
3.7.1 Middle East and Africa Endometriosis Sales by Country
3.7.2 Middle East and Africa Endometriosis Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Endometriosis Historic Market Analysis by Type
4.1 Global Endometriosis Sales Market Share by Type (2017-2022)
4.2 Global Endometriosis Revenue Market Share by Type (2017-2022)
4.3 Global Endometriosis Price by Type (2017-2022)
5 Global Endometriosis Historic Market Analysis by Application
5.1 Global Endometriosis Sales Market Share by Application (2017-2022)
5.2 Global Endometriosis Revenue Market Share by Application (2017-2022)
5.3 Global Endometriosis Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AbbVie Endometriosis Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AstraZeneca Endometriosis Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Bayer HealthCare
6.3.1 Bayer HealthCare Corporation Information
6.3.2 Bayer HealthCare Description and Business Overview
6.3.3 Bayer HealthCare Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer HealthCare Endometriosis Product Portfolio
6.3.5 Bayer HealthCare Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Endometriosis Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Addex Therapeutics
6.5.1 Addex Therapeutics Corporation Information
6.5.2 Addex Therapeutics Description and Business Overview
6.5.3 Addex Therapeutics Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Addex Therapeutics Endometriosis Product Portfolio
6.5.5 Addex Therapeutics Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Astellas Pharma Endometriosis Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 Debiopharm
6.6.1 Debiopharm Corporation Information
6.6.2 Debiopharm Description and Business Overview
6.6.3 Debiopharm Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Debiopharm Endometriosis Product Portfolio
6.7.5 Debiopharm Recent Developments/Updates
6.8 ElexoPharm
6.8.1 ElexoPharm Corporation Information
6.8.2 ElexoPharm Description and Business Overview
6.8.3 ElexoPharm Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.8.4 ElexoPharm Endometriosis Product Portfolio
6.8.5 ElexoPharm Recent Developments/Updates
6.9 EndoCeutics
6.9.1 EndoCeutics Corporation Information
6.9.2 EndoCeutics Description and Business Overview
6.9.3 EndoCeutics Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.9.4 EndoCeutics Endometriosis Product Portfolio
6.9.5 EndoCeutics Recent Developments/Updates
6.10 Euroscreen
6.10.1 Euroscreen Corporation Information
6.10.2 Euroscreen Description and Business Overview
6.10.3 Euroscreen Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Euroscreen Endometriosis Product Portfolio
6.10.5 Euroscreen Recent Developments/Updates
6.11 Forendo Pharma
6.11.1 Forendo Pharma Corporation Information
6.11.2 Forendo Pharma Endometriosis Description and Business Overview
6.11.3 Forendo Pharma Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Forendo Pharma Endometriosis Product Portfolio
6.11.5 Forendo Pharma Recent Developments/Updates
6.12 Kissei Pharmaceutical
6.12.1 Kissei Pharmaceutical Corporation Information
6.12.2 Kissei Pharmaceutical Endometriosis Description and Business Overview
6.12.3 Kissei Pharmaceutical Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Kissei Pharmaceutical Endometriosis Product Portfolio
6.12.5 Kissei Pharmaceutical Recent Developments/Updates
6.13 Neurocrine Biosciences
6.13.1 Neurocrine Biosciences Corporation Information
6.13.2 Neurocrine Biosciences Endometriosis Description and Business Overview
6.13.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Neurocrine Biosciences Endometriosis Product Portfolio
6.13.5 Neurocrine Biosciences Recent Developments/Updates
6.14 Nippon Shinyaku
6.14.1 Nippon Shinyaku Corporation Information
6.14.2 Nippon Shinyaku Endometriosis Description and Business Overview
6.14.3 Nippon Shinyaku Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Nippon Shinyaku Endometriosis Product Portfolio
6.14.5 Nippon Shinyaku Recent Developments/Updates
6.15 Takeda
6.15.1 Takeda Corporation Information
6.15.2 Takeda Endometriosis Description and Business Overview
6.15.3 Takeda Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Takeda Endometriosis Product Portfolio
6.15.5 Takeda Recent Developments/Updates
6.16 Bayer AG
6.16.1 Bayer AG Corporation Information
6.16.2 Bayer AG Endometriosis Description and Business Overview
6.16.3 Bayer AG Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Bayer AG Endometriosis Product Portfolio
6.16.5 Bayer AG Recent Developments/Updates
6.17 Neurocrine Biosciences
6.17.1 Neurocrine Biosciences Corporation Information
6.17.2 Neurocrine Biosciences Endometriosis Description and Business Overview
6.17.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Neurocrine Biosciences Endometriosis Product Portfolio
6.17.5 Neurocrine Biosciences Recent Developments/Updates
7 Endometriosis Manufacturing Cost Analysis
7.1 Endometriosis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Endometriosis
7.4 Endometriosis Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Endometriosis Distributors List
8.3 Endometriosis Customers
9 Endometriosis Market Dynamics
9.1 Endometriosis Industry Trends
9.2 Endometriosis Market Drivers
9.3 Endometriosis Market Challenges
9.4 Endometriosis Market Restraints
10 Global Market Forecast
10.1 Endometriosis Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Endometriosis by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Endometriosis by Type (2023-2028)
10.2 Endometriosis Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Endometriosis by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Endometriosis by Application (2023-2028)
10.3 Endometriosis Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Endometriosis by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Endometriosis by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Endometriosis Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Endometriosis Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Endometriosis Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Endometriosis Market Competitive Situation by Manufacturers in 2021
Table 5. Global Endometriosis Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Endometriosis Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Endometriosis Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Endometriosis Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Endometriosis Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Endometriosis Manufacturing Sites and Area Served
Table 11. Manufacturers Endometriosis Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Endometriosis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Endometriosis Sales by Region (2017-2022) & (K Units)
Table 16. Global Endometriosis Sales Market Share by Region (2017-2022)
Table 17. Global Endometriosis Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Endometriosis Revenue Market Share by Region (2017-2022)
Table 19. North America Endometriosis Sales by Country (2017-2022) & (K Units)
Table 20. North America Endometriosis Sales Market Share by Country (2017-2022)
Table 21. North America Endometriosis Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Endometriosis Revenue Market Share by Country (2017-2022)
Table 23. Europe Endometriosis Sales by Country (2017-2022) & (K Units)
Table 24. Europe Endometriosis Sales Market Share by Country (2017-2022)
Table 25. Europe Endometriosis Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Endometriosis Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Endometriosis Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Endometriosis Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Endometriosis Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Endometriosis Revenue Market Share by Region (2017-2022)
Table 31. Latin America Endometriosis Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Endometriosis Sales Market Share by Country (2017-2022)
Table 33. Latin America Endometriosis Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Endometriosis Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Endometriosis Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Endometriosis Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Endometriosis Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Endometriosis Revenue Market Share by Country (2017-2022)
Table 39. Global Endometriosis Sales by Type (2017-2022) & (K Units)
Table 40. Global Endometriosis Sales Market Share by Type (2017-2022)
Table 41. Global Endometriosis Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Endometriosis Revenue Share by Type (2017-2022)
Table 43. Global Endometriosis Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Endometriosis Sales (K Units) by Application (2017-2022)
Table 45. Global Endometriosis Sales Market Share by Application (2017-2022)
Table 46. Global Endometriosis Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Endometriosis Revenue Share by Application (2017-2022)
Table 48. Global Endometriosis Price by Application (2017-2022) & (USD/Unit)
Table 49. AbbVie Corporation Information
Table 50. AbbVie Description and Business Overview
Table 51. AbbVie Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. AbbVie Endometriosis Product
Table 53. AbbVie Recent Developments/Updates
Table 54. AstraZeneca Corporation Information
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. AstraZeneca Endometriosis Product
Table 58. AstraZeneca Recent Developments/Updates
Table 59. Bayer HealthCare Corporation Information
Table 60. Bayer HealthCare Description and Business Overview
Table 61. Bayer HealthCare Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Bayer HealthCare Endometriosis Product
Table 63. Bayer HealthCare Recent Developments/Updates
Table 64. Pfizer Corporation Information
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Pfizer Endometriosis Product
Table 68. Pfizer Recent Developments/Updates
Table 69. Addex Therapeutics Corporation Information
Table 70. Addex Therapeutics Description and Business Overview
Table 71. Addex Therapeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Addex Therapeutics Endometriosis Product
Table 73. Addex Therapeutics Recent Developments/Updates
Table 74. Astellas Pharma Corporation Information
Table 75. Astellas Pharma Description and Business Overview
Table 76. Astellas Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Astellas Pharma Endometriosis Product
Table 78. Astellas Pharma Recent Developments/Updates
Table 79. Debiopharm Corporation Information
Table 80. Debiopharm Description and Business Overview
Table 81. Debiopharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Debiopharm Endometriosis Product
Table 83. Debiopharm Recent Developments/Updates
Table 84. ElexoPharm Corporation Information
Table 85. ElexoPharm Description and Business Overview
Table 86. ElexoPharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. ElexoPharm Endometriosis Product
Table 88. ElexoPharm Recent Developments/Updates
Table 89. EndoCeutics Corporation Information
Table 90. EndoCeutics Description and Business Overview
Table 91. EndoCeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. EndoCeutics Endometriosis Product
Table 93. EndoCeutics Recent Developments/Updates
Table 94. Euroscreen Corporation Information
Table 95. Euroscreen Description and Business Overview
Table 96. Euroscreen Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Euroscreen Endometriosis Product
Table 98. Euroscreen Recent Developments/Updates
Table 99. Forendo Pharma Corporation Information
Table 100. Forendo Pharma Description and Business Overview
Table 101. Forendo Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Forendo Pharma Endometriosis Product
Table 103. Forendo Pharma Recent Developments/Updates
Table 104. Kissei Pharmaceutical Corporation Information
Table 105. Kissei Pharmaceutical Description and Business Overview
Table 106. Kissei Pharmaceutical Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Kissei Pharmaceutical Endometriosis Product
Table 108. Kissei Pharmaceutical Recent Developments/Updates
Table 109. Neurocrine Biosciences Corporation Information
Table 110. Neurocrine Biosciences Description and Business Overview
Table 111. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Neurocrine Biosciences Endometriosis Product
Table 113. Neurocrine Biosciences Recent Developments/Updates
Table 114. Nippon Shinyaku Corporation Information
Table 115. Nippon Shinyaku Description and Business Overview
Table 116. Nippon Shinyaku Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Nippon Shinyaku Endometriosis Product
Table 118. Nippon Shinyaku Recent Developments/Updates
Table 119. Takeda Corporation Information
Table 120. Takeda Description and Business Overview
Table 121. Takeda Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Takeda Endometriosis Product
Table 123. Takeda Recent Developments/Updates
Table 124. Bayer AG Corporation Information
Table 125. Bayer AG Description and Business Overview
Table 126. Bayer AG Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Bayer AG Endometriosis Product
Table 128. Bayer AG Recent Developments/Updates
Table 129. Neurocrine Biosciences Corporation Information
Table 130. Neurocrine Biosciences Description and Business Overview
Table 131. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Neurocrine Biosciences Endometriosis Product
Table 133. Neurocrine Biosciences Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Endometriosis Distributors List
Table 137. Endometriosis Customers List
Table 138. Endometriosis Market Trends
Table 139. Endometriosis Market Drivers
Table 140. Endometriosis Market Challenges
Table 141. Endometriosis Market Restraints
Table 142. Global Endometriosis Sales Forecast by Type (2023-2028) & (K Units)
Table 143. Global Endometriosis Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Endometriosis Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Endometriosis Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Endometriosis Sales Forecast by Application (2023-2028) & (K Units)
Table 147. Global Endometriosis Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Endometriosis Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Endometriosis Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Endometriosis Sales Forecast by Region (2023-2028) & (K Units)
Table 151. Global Endometriosis Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Endometriosis Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Endometriosis Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endometriosis
Figure 2. Global Endometriosis Market Share by Type in 2021 & 2028
Figure 3. Gonadotropins Releasing Hormone Agonists Product Picture
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Progestin Product Picture
Figure 6. Oral Contraceptive Pills Product Picture
Figure 7. Global Endometriosis Market Share by Application in 2021 & 2028
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Other
Figure 11. Global Endometriosis Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Endometriosis Market Size (2017-2028) & (US$ Million)
Figure 13. Global Endometriosis Sales (2017-2028) & (K Units)
Figure 14. Endometriosis Sales Share by Manufacturers in 2021
Figure 15. Global Endometriosis Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Endometriosis Players: Market Share by Revenue in 2021
Figure 17. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Endometriosis Sales Market Share by Region (2017-2022)
Figure 19. Global Endometriosis Sales Market Share by Region in 2021
Figure 20. Global Endometriosis Revenue Market Share by Region (2017-2022)
Figure 21. Global Endometriosis Revenue Market Share by Region in 2021
Figure 22. U.S. Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Endometriosis Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Endometriosis by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Endometriosis
Figure 48. Manufacturing Process Analysis of Endometriosis
Figure 49. Endometriosis Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie AstraZeneca Bayer HealthCare Pfizer Addex Therapeutics Astellas Pharma Debiopharm ElexoPharm EndoCeutics Euroscreen Forendo Pharma Kissei Pharmaceutical Neurocrine Biosciences Nippon Shinyaku Takeda Bayer AG Neurocrine Biosciences